S A Muir-Paulik1, L E A Johnson2, P Kennedy3, T Aden4, J Villanueva2, E Reisdorf5, R Humes6, A C Moen2. 1. Association of Public Health Laboratories, 8515 Georgia Avenue, Suite 700, Silver Spring, MD 20910, USA. Electronic address: smuirpaulik@gmail.com. 2. Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA 30329, USA. 3. McKing Consulting Corporation, 2810 Old Lee Highway, Suite 300 Fairfax, VA 22031, USA. 4. Battelle Memorial Institute, King Avenue, Columbus, OH 43201, USA. 5. Wisconsin State Laboratory of Hygiene, 465 Henry Mall, Madison, WI 53706, USA. 6. Biomedical Advanced Research Development Authority, Office of the Assistant Secretary for Preparedness and Response, Health and Human Services, 200 C St. SW, Washington, DC 20024, USA.
Abstract
OBJECTIVES: The 2005 International Health Regulations (IHR 2005) emphasized the importance of laboratory capacity to detect emerging diseases including novel influenza viruses. To support IHR 2005 requirements and the need to enhance influenza laboratory surveillance capacity, the Association of Public Health Laboratories (APHL) and the Centers for Disease Control and Prevention (CDC) Influenza Division developed the International Influenza Laboratory Capacity Review (Tool). STUDY DESIGN: Data from 37 assessments were reviewed and analyzed to verify that the quantitative analysis results accurately depicted a laboratory's capacity and capabilities. METHODS: Subject matter experts in influenza and laboratory practice used an iterative approach to develop the Tool incorporating feedback and lessons learnt through piloting and implementation. To systematically analyze assessment data, a quantitative framework for analysis was added to the Tool. RESULTS: The review indicated that changes in scores consistently reflected enhanced or decreased capacity. The review process also validated the utility of adding a quantitative analysis component to the assessments and the benefit of establishing a baseline from which to compare future assessments in a standardized way. CONCLUSIONS: Use of the Tool has provided APHL, CDC and each assessed laboratory with a standardized analysis of the laboratory's capacity. The information generated is used to improve laboratory systems for laboratory testing and enhance influenza surveillance globally. We describe the development of the Tool and lessons learnt.
OBJECTIVES: The 2005 International Health Regulations (IHR 2005) emphasized the importance of laboratory capacity to detect emerging diseases including novel influenza viruses. To support IHR 2005 requirements and the need to enhance influenza laboratory surveillance capacity, the Association of Public Health Laboratories (APHL) and the Centers for Disease Control and Prevention (CDC) Influenza Division developed the International Influenza Laboratory Capacity Review (Tool). STUDY DESIGN: Data from 37 assessments were reviewed and analyzed to verify that the quantitative analysis results accurately depicted a laboratory's capacity and capabilities. METHODS: Subject matter experts in influenza and laboratory practice used an iterative approach to develop the Tool incorporating feedback and lessons learnt through piloting and implementation. To systematically analyze assessment data, a quantitative framework for analysis was added to the Tool. RESULTS: The review indicated that changes in scores consistently reflected enhanced or decreased capacity. The review process also validated the utility of adding a quantitative analysis component to the assessments and the benefit of establishing a baseline from which to compare future assessments in a standardized way. CONCLUSIONS: Use of the Tool has provided APHL, CDC and each assessed laboratory with a standardized analysis of the laboratory's capacity. The information generated is used to improve laboratory systems for laboratory testing and enhance influenza surveillance globally. We describe the development of the Tool and lessons learnt.
Authors: Lucinda E A Johnson; Sarah A Muir-Paulik; Pam Kennedy; Steven Lindstrom; Amanda Balish; Tricia Aden; Ann C Moen Journal: BMC Infect Dis Date: 2015-11-06 Impact factor: 3.090
Authors: Adaeze Ogee-Nwankwo; David Opare; Gifty Boateng; Mawuli Nyaku; Lia M Haynes; S Arunmozhi Balajee; Laura Conklin; Joseph P Icenogle; Paul A Rota; Diane Waku-Kouomou Journal: Emerg Infect Dis Date: 2017-12 Impact factor: 6.883